Hopital Bichat - Claude Bernard AP-HP

Paris 75877

2 studies enrolling now · 3 studies all time

What they study most

Advanced Cancer, Brain Tumor, Colon Cancer, EGFR Gene Mutation, Exon 14 Skipping, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Glioblastoma Multiforme, HER2 Exon 20 Mutation, HGF, Lung Cancer, MET Alteration

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression — Recruiting now
• APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors — Recruiting now
• Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy — Completed